Short-Term Cost-Effectiveness Analysis of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn (Nph) In Patients With Type 2 Diabetes Mellitus in Spain
Value Health
.
2014 Nov;17(7):A343.
doi: 10.1016/j.jval.2014.08.686.
Epub 2014 Oct 26.
Authors
de Arellano A Ramírez
1
,
C Morales
2
,
Luis D De
3
,
M G Ferrario
4
,
L Lizán
5
Affiliations
1
Novo Nordisk Pharma SA, Madrid, Spain.
2
Hospital Virgen de la Macarena, Sevilla, Spain.
3
Hospital Rio Hortega, Valladolid, Spain.
4
Outcomes'10, Castellon, Spain.
5
Outcomes 10, Castellon, Spain.
PMID:
27200637
DOI:
10.1016/j.jval.2014.08.686
No abstract available